Learn · Part 1. Foundations · 5 min read
The stressors: exercise, vasodilators and dobutamine
How exercise, vasodilators and dobutamine provoke or reveal ischemia, and what makes an exercise test adequate.
60-second take
- Exercise raises demand, vasodilators open the coronary vessels and expose a flow difference, and dobutamine raises heart rate and contractility.
- Exercise is preferred when the patient can reach an adequate workload. Pharmacologic stress covers those who cannot, with vasodilators first-line for nuclear perfusion imaging.
- Adequate exercise is judged by symptoms, ECG, workload and heart rate together. The usual reference points are 85% of the age-predicted maximum heart rate and 80% of predicted workload.
- Dobutamine is the usual alternative when exercise is not possible and vasodilators are contraindicated.
- Full contraindication detail is in Part 4, Safety.
Three ways to provoke or reveal ischemia
All stressors work on the same weak point: a limited flow reserve. They differ in how they reach it.
- Exercise raises demand. Cardiac output must rise to feed the working muscles, and the heart’s own energy demand rises with it. If coronary flow cannot follow, ischemia develops .
- Vasodilators open the vessels. Adenosine, regadenoson and dipyridamole all dilate the coronary arterioles through the same adenosine pathway and raise coronary flow several-fold . Territories that can dilate fully show a large rise; territories behind a narrowing cannot, so a flow difference appears between them. This is why vasodilators are paired with perfusion imaging.
- Dobutamine raises rate and contractility. It stimulates beta-1, alpha-1 and beta-2 receptors, raising heart rate, blood pressure and contractility, which increases oxygen demand in the same way exercise does . Normal coronary arteries respond with a compensatory rise in flow.
The agents
- Adenosine is a direct coronary vasodilator. Its effect peaks 2 to 3 minutes after the infusion starts and wears off quickly, because its half-life is about 10 seconds .
- Regadenoson is a selective agonist of the same A2A receptor. Because it lasts longer, it is given as a single bolus rather than an infusion, and it is the preferred vasodilator in mild to moderate reactive airway disease .
- Dipyridamole works indirectly, by raising tissue adenosine. Its hyperemia lasts more than 50 minutes .
- Dobutamine, with atropine added when needed to reach the target heart rate, is the usual alternative when exercise is not possible and vasodilators are contraindicated .
| Stressor | How it works | Typical situation | Main limitation |
|---|---|---|---|
| Exercise (treadmill or bicycle) | Raises demand physiologically | Preferred when the patient can exercise adequately | Needs adequate effort, and not everyone can give it |
| Vasodilators (adenosine, regadenoson, dipyridamole) | Dilate coronary arterioles and raise flow | Cannot exercise adequately; also flow quantification and left bundle branch block or ventricular pacing | Caffeine and other methylxanthines must be avoided beforehand ; actions on other adenosine receptors cause side effects |
| Dobutamine (± atropine) | Raises rate, pressure and contractility | Cannot exercise and vasodilators are contraindicated ; also the echo choice for viability | Less robust hyperemia, more side effects, and an inefficient protocol for nuclear imaging |
Which stressor fits depends partly on the imaging test. For stress echo, the ASE calls dobutamine a preferred alternative when a patient cannot exercise , and lists vasodilators as preferred for myocardial perfusion . For nuclear perfusion imaging, vasodilators are the first-choice pharmacologic agents . In cardiac MRI, vasodilator perfusion testing is more common than dobutamine functional testing .
What makes an exercise test adequate
An exercise test is symptom-limited: the patient keeps going until moderate to severe chest pain, excessive breathlessness, fatigue or another reason to stop . Two numbers are quoted most often.
- Heart rate. The usual target is 85% of the age-predicted maximum, commonly calculated as 220 minus age .
- Workload in METs. One MET is about 3.5 mL of oxygen per kg per minute. Expected capacity falls with age and differs by sex, and capacity below 85% of predicted is linked to worse prognosis . Reaching at least 10 METs is considered a favorable sign .
The appropriate use criteria assume exercise to a symptomatic endpoint, reaching at least 80% of the age- and sex-predicted workload, or at least 85% of the age-predicted maximum heart rate (definition) . The ASE likewise treats 80% of predicted workload as a diagnostic endpoint .
Why it matters: if the stress is too weak, a normal result is less reassuring. The ASE notes that falling short of 80% of predicted workload may reduce sensitivity, and that continuing to symptoms may uncover abnormalities that appear only at high workload . A heart rate below 85% is an example the criteria give of an inconclusive exercise test .
Try it
How do the usual adequacy numbers work out?
Reference point: 85% of age-predicted maximum heart rate
Reference point: 80% of the age- and sex-predicted workload
This shows arithmetic, not a verdict. Symptoms, ST changes, the blood pressure response, and the patient’s effort all matter, and the same numbers can mean different things on beta blockers or in a very fit person. Heart rate predicted as 220 minus age; predicted METs as 14.7 minus 0.13 times age (women) or 18.0 minus 0.15 times age (men).
Example from the tool
Inconclusive ET
An exercise test that is not diagnostic is one of the situations the criteria cover. Here is how they rate the next step.
- Exercise ECGNot applicable
- Exercise SPECTAppropriate
- Pharmacologic SPECTAppropriate
- Pharmacologic PETAppropriate
- Exercise echoAppropriate
- Dobutamine echoAppropriate
- Stress CMRAppropriate
- CAC scoreMay Be Appropriate
- CCTAAppropriate
- Invasive angiographyMay Be Appropriate
- No testRarely Appropriate
Who cannot exercise enough to matter
The chest pain guideline describes good candidates for an exercise ECG as people without disabling comorbidity, such as frailty, a body mass index over 40, peripheral artery disease, chronic obstructive pulmonary disease or orthopedic limits, who can manage daily activities or reach at least 5 METs . Pharmacologic stress is the route for patients who cannot exercise, cannot reach an adequate level, or for whom exercise is contraindicated .
Some patients who can exercise still get a vasodilator, for example with left bundle branch block or ventricular pacing on perfusion imaging, because exercise-related heart rate artifacts can mimic ischemia . The full detail on what rules each stressor in or out belongs to Part 4, Safety.
Exercise versus pharmacologic stress
Exercise
Strengths
- Preferred when the patient can exercise adequately and reach a meaningful workload
- Preserves the normal electromechanical response and yields functional capacity, which carries prognostic weight
- Reproduces symptoms and records heart rate, blood pressure and ECG responses
- In patients headed for stress imaging who can exercise, preferred for the diagnostic and prognostic information it adds
Limitations
- Only as good as the effort given: a weak test can be inconclusive
- In echo, post-exercise images must be taken within 1 to 2 minutes, before wall motion changes fade
- Adverse events from the physiologic stress are uncommon but more frequent in higher-risk patients
Pharmacologic stress
Strengths
- Works for patients who cannot exercise, cannot reach an adequate level, or for whom exercise is contraindicated
- Vasodilators are the first-choice agents, and suit flow quantification and patients with left bundle branch block or ventricular pacing
- Dobutamine covers patients who cannot take a vasodilator
Limitations
- Gives no exercise capacity, the prognostic finding that exercise adds
- Agent-specific side effects, and caffeine and other methylxanthines must be avoided beforehand for vasodilator stress
- Dobutamine gives less robust hyperemia and more side effects than vasodilators
| Agent | Dose and timing in the ASNC guideline |
|---|---|
| Regadenoson | Fixed 0.4 mg (5 mL) bolus over about 10 seconds, with no adjustment for body size, renal function, liver function or age |
| Adenosine | 140 mcg/kg/min; the standard protocol runs 6 minutes with the tracer injected at 3 minutes, and a 4-minute version is an alternative |
| Dipyridamole | 0.56 mg/kg over 4 minutes |
| Dobutamine | Start at 5 or 10 mcg/kg/min and step up every 3 minutes through 20, 30 and 40 (sometimes 50) mcg/kg/min until the target heart rate is reached; atropine is given in 0.25 to 0.5 mg doses up to 2 mg total if needed |
If exercise is inadequate and there are no diagnostic ST changes or typical angina, the radiotracer should not be injected. The test can be completed with a pharmacologic agent. Patients below a minimal threshold, such as under 5 METs or under 4 to 6 minutes of exercise, or clearly below expected capacity for age and sex, may be candidates .
The decision should weigh the whole picture rather than a single number. In the EXERRT trial, regadenoson given during recovery was safe when no ischemia was evident. If ST depression or angina occurs, the tracer can be given at peak exercise instead .
Walking at low treadmill speed during adenosine, regadenoson or dipyridamole stress reduces side effects and extracardiac tracer uptake, and improves image quality. It is not recommended with left bundle branch block or ventricular pacing, because of heart rate-related artifacts .
For a specific patient, use the scenario builder → to see how the criteria and the contraindication registry apply to the stressor you are considering.
Try it in the tool
Sources cited on this page
Click a tag for the full reference. All references